Vanguard Global Advisers »

Tg Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.8M 56k 33.22

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Soleus Capital Management
Geode Capital Management
ClearBridge Advisors
Jane Street
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Congress Asset Management
Pictet Asset Management Holding SA
Hood River Capital Management

View all funds holding Tg Therapeutics